MPO and Parkinson disease: Moreover, the recent study have demonstrated that the increase in NOX4 interacts with the neuroinflammatory mediators (MPO and OPN) to control ferroptosis through astrocytic mitochondrial dysfunction in the hippocampus during PD, as observed when comparing an MPTP-induced PD mouse model with human PD patients [56].